Genus plc (LON:GNS) Receives Average Recommendation of “Hold” from Analysts

Shares of Genus plc (LON:GNSGet Rating) have received a consensus rating of “Hold” from the seven ratings firms that are presently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is GBX 5,391.43 ($66.47).

Separately, Peel Hunt reaffirmed a “hold” rating and issued a GBX 4,500 ($55.48) price objective on shares of Genus in a report on Tuesday, April 12th.

Shares of GNS stock traded up GBX 88 ($1.08) during trading hours on Friday, hitting GBX 2,544 ($31.36). The company’s stock had a trading volume of 55,101 shares, compared to its average volume of 98,604. The company has a 50 day moving average of GBX 2,731.01 and a 200 day moving average of GBX 3,856.01. The stock has a market cap of £1.67 billion and a PE ratio of 45.27. The company has a current ratio of 1.77, a quick ratio of 1.13 and a debt-to-equity ratio of 37.36. Genus has a 12-month low of GBX 2,186 ($26.95) and a 12-month high of GBX 6,310 ($77.80).

The company also recently declared a dividend, which was paid on Thursday, March 31st. Investors of record on Thursday, March 3rd were issued a dividend of GBX 10.30 ($0.13) per share. This represents a yield of 0.33%. The ex-dividend date was Thursday, March 3rd. Genus’s dividend payout ratio (DPR) is presently 56.94%.

About Genus (Get Rating)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.

See Also

Analyst Recommendations for Genus (LON:GNS)

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with's FREE daily email newsletter.